Depression

  • In an unusual trial, Stanford Medicine researchers found that a patient’s belief that they had received ketamine, even if they didn’t, could improve their depression.

  • Depression after stroke

    Scientists discover a biomarker in stroke survivors, suggesting that chemical changes after stroke can lead to depression. The findings may pave the way toward treatment.

  • Classifying a type of depression

    Using surveys, cognitive tests and brain imaging, researchers have identified a type of depression that affects about a quarter of patients. The goal is to diagnose and treat the condition more precisely.

  • Reversing brain signals treats depression

    A new study led by Stanford Medicine researchers is the first to reveal how magnetic stimulation treats severe depression: by correcting the abnormal flow of brain signals.

  • Shebani Sethi on metabolic psychiatry

    A specialist in psychiatry and obesity describes how metabolic disorders affect the brain and how nutrition can help patients with mental illness.

  • Parents’ PTSD after child’s medical trauma

    Nearly half of parents with a child who received an implantable device to correct abnormal heart rhythms met criteria for post-traumatic stress disorder, a Stanford Medicine-led study found.

  • Physicians feel more unaccomplished

    In what authors believe to be the largest study of its kind, Stanford Medicine researchers found that impostor syndrome is more prevalent in physicians than in other U.S. workers.

  • Epilepsy linked to mood symptoms in pregnancy

    Stanford-led study gives new insight into how epilepsy, pregnancy and symptoms of mood disorders interact.

  • Study: New depression treatment effective

    In a double-blind controlled study, high doses of magnetic brain stimulation, given on an accelerated timeline and individually targeted, caused remission in 79% of trial participants with severe depression.

  • Test therapy for depression found to be effective

    Stanford Medicine researchers used high doses of magnetic stimulation, delivered on an accelerated timeline and targeted to individual neurocircuitry, to treat patients with severe depression.

Related Websites